{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-177438","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.212352+00:00","generated_at":"2026-05-17T15:07:45.275123+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"WeightWatchers emerges from reorganization, cuts debt $1.15B; Q2 combined revenue down 6%","bullets":["Completed strategic reorganization on June 24, reducing debt by $1.15 billion and applying fresh-start accounting.","Q2 combined revenue $189M (-6% YoY); clinical revenue up 55% to $31M, driven by compounded semaglutide.","Combined end-of-period subscribers 3.2M (-17% YoY); clinical subscribers 127K (+56% YoY).","Predecessor net income $1,191M (includes reorganization items); Successor net income $1M.","FY 2025 guidance: combined revenue $685M-$700M, adjusted EBITDA $140M-$150M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-177438","json":"https://secwatch.observer/filing/0001193125-25-177438.json","markdown":"https://secwatch.observer/filing/0001193125-25-177438.md","text":"https://secwatch.observer/filing/0001193125-25-177438.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312525177438/0001193125-25-177438-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312525177438/d71795d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:07:45.275123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}